Alexion Pharma (Switzerland)

Alexion Pharma (Switzerland)

Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alexion Pharma (Switzerland), Switzerland, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

57%


Total
Publications

124


Total Open
Publications

71


Total
Citations

1.8K


Open Access
Percentage

57%


Total
Publications

124


Total Open
Publications

71


Total
Citations

1.8K

Wikipedia

Website

download

Breakdown

26% 28% 3% 43%

Publisher Open

26%

Both

28%

Other Platform Open

3%

Closed

43%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

33%OA Journal

OA Journal 33%

22

Hybrid 28%

19

No Guarantees 39%

26

Other Platform Open

Domain 72%

28

Institution 49%

19

Public 5%

2

Preprint 3%

1

Other Internet 3%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
28
Europe PMC
Domain
17
Ghent University - Ghent University Academic Bibliography
Institution
9
Radboud University - Radboud Repository
Institution
4
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
3
Newcastle Univesity - Newcastle University ePrints
Institution
3
University of Nottingham - Repository@Nottingham
Institution
2
University of Geneva - Archive ouverte UNIGE
Institution
2
Semantic Scholar
Public
2
Université de Lausanne - SERVAL
Institution
1
1 / 3

Data updated 17 June 2024

Share

Share

Share